Elicio Therapeutics, Inc.ELTXNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank44
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-37.71M
↓ 30% vs avg
Percentile
P44
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-29.05M
Historical baseline
PeriodValueYoY Change
TTM$-37.71M+16.2%
2024$-44.99M-25.9%
2023$-35.74M-50.6%
2022$-23.73M+39.6%
2021$-39.31M+28.9%
2020$-55.27M-43.2%
2019$-38.59M-169.1%
2018$-14.34M-3505.3%
2013$-397800.00+5.1%
2012$-419220.00-